CBP treatment increased the secretion of HA in ovarian cancer cell lines by increasing HA synthesis, as we found corresponding increased Has2 and Has3 expression in OVCAR-5 and increased Has3 expression in OV-90 and OVCAR-3 cells. The gene discussed is HAS2; the disease is ovarian carcinoma.